EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The role of new inflammatory markers in determining disease activation and severity in patients with hidradenitis suppurativa

Eda Öksüm Solak, Burcu Baran Ketencioglu, Salih L Cinar, Demet Kartal, Murat Borlu

International Journal of Dermatology · 2023

DOI: 10.1111/ijd.16744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, 2023. Verfasst von Eda Öksüm Solak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology and Venereology Department, Erciyes University Medical School, Kayseri, Turkey. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hidradenitis suppurativa (HS) is a chronic inflammatory disease. Recently published studies have suggested the use of markers of inflammation to monitor HS patients. These studies discuss the platelet/lymphocyte ratio (PLR), neutrophil/lymphocyte ratio (NLR), pan‐immune‐inflammation value (PIV), and systemic immune‐inflammation index (SIII), which are also used in other inflammatory diseases. This study aimed to compare the blood parameters, including NLR, PLR, SIII, and PIV, in HS patients and healthy individuals, and determine their correlation with disease severity. The study included 81 HS patients and 61 healthy volunteers. The patients' medical records and laboratory values of the control group were reviewed retrospectively. HS severity was assessed using Hurley staging. NLR, PLR, SIII, and PIV values were calculated based on complete blood counts. NLR, SIII, and PIV values were significantly higher in HS patients compared to the healthy control group and were positively associated with disease severity. There was no significant difference observed in PLR values concerning disease severity. This study suggests that NLR, SIII, and PIV values can be utilized as simple and cost‐effective tests to monitor disease activity and severity in HS patients. However, larger and more comprehensive studies are needed to establish diagnostic cutoff values, and further evaluation of sensitivity and specificity is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaHumansRetrospective StudiesLymphocytesInflammationBlood PlateletsNeutrophils

Autor:innen und Institutionen

  • Dermatology and Venereology Department, Erciyes University Medical School, Kayseri, Turkey.
  • Department of Chest Diseases, Erciyes University Medical School, Kayseri, Turkey.

Zitieren

APA

Öksüm Solak, E., Baran Ketencioglu, B., Cinar, S. L., Kartal, D., & Borlu, M. (2023). The role of new inflammatory markers in determining disease activation and severity in patients with hidradenitis suppurativa. International Journal of Dermatology. https://doi.org/10.1111/ijd.16744

Vancouver

Öksüm Solak E, Baran Ketencioglu B, Cinar SL, Kartal D, Borlu M. The role of new inflammatory markers in determining disease activation and severity in patients with hidradenitis suppurativa. International Journal of Dermatology. 2023. doi:10.1111/ijd.16744

BibTeX
@article{ksmSolak2023,
  author = {Öksüm Solak, Eda and Baran Ketencioglu, Burcu and Cinar, Salih L and Kartal, Demet and Borlu, Murat},
  title = {The role of new inflammatory markers in determining disease activation and severity in patients with hidradenitis suppurativa},
  journal = {International Journal of Dermatology},
  year = {2023},
  doi = {10.1111/ijd.16744}
}
Kostenlos starten →